| Announce Date | 12/15/2025 |
| EPS Normalized Actual | $-0.85 (Beat by $0.05) |
| EPS GAAP Actual | $-0.85 (Beat by $0.05) |
| Revenue Actual | $2.419E-6B |
| Revenue Surprise | Beat by $0.002419M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.86 |
| EPS GAAP Estimate | $-0.86 |
| Revenue Estimate | $0.0001B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2027 | -0.03 | -105.33 | -0.03 | -0.03 | -3 |
| Apr 2026 | -1.315 | -2.4 | -1.315 | -1.315 | -1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.85 | -0.84 | 2.419E-6B | 100% | -2M |
| FQ3 2025 (Jul 2025) | -1.58 | -1.57 | 0.0019B | 100% | 0.4M |
| FQ2 2025 (Apr 2025) | -1.88 | -0.09 | 4.35E-6B | 100% | -0.05M |
| FQ1 2025 (Jan 2025) | -2.57 | -0.94 | 0B | -INF% | -0.55M |
| FQ4 2024 (Oct 2024) | -2.27 | -3.81141 | 0B | -INF% | 0M |
| FQ3 2024 (Jul 2024) | -2.64 | -2.64 | 0B | NAN% | 0M |
| FQ2 2024 (Apr 2024) | 0 | 0 | 0B | NAN% | 0M |
| FQ1 2024 (Jan 2024) | -0.0306 | -0.0306 | 1.47E-5B | 100% | 0.01M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.86
Consensus Revenue Estimates
0.0001B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | -0.84 | -- | -0.84 | -0.84 | 1 |
| FQ4 2026 (Oct 2026) | -1.11 | 23.42 | -1.11 | -1.11 | 1 |
| FQ3 2026 (Jul 2026) | -1.07 | -47.66 | -1.07 | -1.07 | 1 |
| FQ2 2026 (May 2026) | -1.265 | -48.62 | -1.265 | -1.265 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0B | -- | 0B | 0B | 1 |
| FQ4 2026 (Oct 2026) | 0B | 97.58 | 0B | 0B | 1 |
| FQ3 2026 (Jul 2026) | 0B | -58705.32 | 0B | 0B | 1 |
| FQ2 2026 (May 2026) | 0B | 99.57 | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
2
Revenue # of Misses
3
Revenue # of in-lines
3
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.01 | -0.85 | -0.84 | 98.82% |
| FQ3 2025 (Jul 2025) | -0.01 | -1.58 | -1.57 | 99.37% |
| FQ2 2025 (Apr 2025) | -1.79 | -1.88 | -0.09 | 4.79% |
| FQ1 2025 (Jan 2025) | -1.63 | -2.57 | -0.94 | 36.58% |
| FQ4 2024 (Oct 2024) | 1.54141 | -2.27 | -3.81141 | 167.9% |
| FQ3 2024 (Jul 2024) | -2.64 | -2.64 | 100% | |
| FQ2 2024 (Apr 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Jan 2024) | -0.0306 | -0.0306 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $0B | $-2M | -82578.79% |
| FQ3 2025 (Jul 2025) | $0B | $0B | $0.4M | 21.05% |
| FQ2 2025 (Apr 2025) | $0B | $0B | $-0.05M | -1049.43% |
| FQ1 2025 (Jan 2025) | $0B | $0B | $-0.55M | -INF% |
| FQ4 2024 (Oct 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Jul 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Apr 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Jan 2024) | $0B | $0B | $0.01M | 100% |